Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

Helicobacter Pylori

Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota

J Gastroenterol Hepatol.

Liou JM, Lee YC, Wu MS

doi: 10.1111/jgh.14992.

Helicobacter Pylori

Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta-analysis

Helicobacter.

Ye Q, Shao X, Shen R, Chen D, Shen J

doi: 10.1111/hel.12713.

Helicobacter Pylori

The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis

Helicobacter.

Zou Y, Qian X, Liu X, Song Y, Song C, Wu S, An Y, Yuan R, Wang Y, Xie Y

doi: 10.1111/hel.12714.

Helicobacter Pylori

Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial

Helicobacter.

Kakiuchi T, Mizoe A, Yamamoto K, Imamura I, Hashiguchi K, Kawakubo H, Yamaguchi D, Fujioka Y, Nakayama A, Okuda M, Matsuo M

doi: 10.1111/hel.12690.

Helicobacter Pylori

Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Gut.

Suzuki S, Gotoda T, Kusano C, Ikehara H, Ichijima R, Ohyauchi M, Ito H, Kawamura M, Ogata Y, Ohtaka M, Nakahara M, Kawabe K

doi: 10.1136/gutjnl-2019-319954.

Helicobacter Pylori

Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication

J Antimicrob Chemother.

De Francesco V, Zullo A, Fiorini G, Saracino IM, Pavoni M, Vaira D

doi: 10.1093/jac/dky469.

Gastrointestinal CancerHelicobacter Pylori

Long-term follow-up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication

J Gastroenterol Hepatol.

Noh G, Kim N, Choi Y, Lee HS, Hwang YJ, Kim HJ, Yoon H, Shin CM, Park YS, Lee DH

doi: 10.1111/jgh.15017.

Gastrointestinal Cancer

Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial

Lancet Gastroenterol Hepatol

Park JW, Kang SB, Hao J, Lim SB, Choi HS, Kim DW, Chang HJ, Kim DY, Jung KH, Kim TY, Kang GH, Chie EK, Kim SY, Sohn DK, Kim JS, Lee HS, Kim JH, Jeong SY, Oh JH

doi: 10.1016/S2468-1253(21)00094-7

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains

Aliment Pharmacol Ther.

Gatta L, Scarpignato C, Fiorini G, Belsey J, Saracino IM, Ricci C, Vaira D

doi: 10.1111/apt.14597.

Related content

Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota

Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta-analysis

The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis

Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial

Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication

Long-term follow-up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication

Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains